Gets support for AMD RDNA 4 and Nvidia Blackwell GPUs. Maxon has released the newest version of its Cinebench benchmarking tool. Based on the Redshift rendering engine and adds su ...

Maxon introduces Cinebench 2026, the latest benchmark with support for Nvidia Blackwell and AMD Radeon 9000 GPUs, Apple M4/M5 ...

On Monday, Maxon announced Cinebench 2026, the latest version of its benchmarking software for testing CPU and GPU ...

Moza makes some of the best (and best value) sim racing gear available, from affordable entry-level bundles to increasingly exotic wheel bases, wheel rims and pedals. We're looking at the latter end ...

Bubsy 4D has taken me by surprise. Though I grew up gaming through the '90s and playing a lot of platformers, this bobcat never grabbed me, his maligned jump into 3D doing him no favors. Which is why ...

The washed-up platforming mascot is back. Again. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on Google Polite ...

Let’s get one thing out of the way: I hate Bubsy. Not Bubsy 4D, the interesting, vibrant game I’m actually previewing here, but rather Bubsy himself, the mangy, atrocious feline, a poisonous product ...

On the first day of the Hungry Ghost Month last Saturday (Aug 23), a group of devotees in Sembawang struck it big after betting on a 'lucky' 4D number posted at the prayer altar. The 'lucky' number ...

The Moza Racing R25 is the company's most powerful direct drive sim racing wheel base ever - and it's a beast. Here's a hands-on, first look at the device, which is by no means a review - that's for ...

Publisher Atari and developer Fabraz have announced Bubsy 4D for PlayStation 5, Xbox Series, Switch 2, PlayStation 4, Xbox One, Switch, and PC (Steam, Epic Games Store, GOG). A release date was not ...

Bubsy the Bobcat, star of the eponymous, oft-derided Bubsy series of hit-or-miss platforming games, is back in a new adventure called Bubsy 4D. Publisher Atari and developer Fabraz, known for the ...

4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading. The ...